Phaseline

Targets › FDG

FDG: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Oncology; next expected readout Jun 2030.

Open in Phaseline: the race on FDG, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Akiva Mintz18F-FDG
Fluorine-18 fluorodeoxyglucose (18F-FDG) is a radioactive glucose analog used as a metabol
FDGPhase 2Healthy VolunteerJun 2030

Conditions

Healthy Volunteer (1)

Modalities

small molecule (1)

Companies

Akiva Mintz (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.